drugset / Trial / NCT06745518
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
RandomizedParallel-groupTriple-blindTreatment
Summary
A phase 2, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
Timeline
- Start
- 2025-01-06
- Primary completion
- 2025-07-15
- Completion
- 2025-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
| Subject | TS-172 | Unknown | 60 mg | Oral |